Abstract
A series of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential telomerase inhibitors were synthesized. The bioassay tests showed that compound 3b exhibited potentially high activity against human gastric cancer cell SGC-7901 with IC50 value was 2.98±0.16. Docking simulation was performed to position compound 3b into the telomerase (3DU6) active site to determine the probable binding model. The result shows that some coumarin containing 4,5-dihydropyrazole moiety can combine well with the telomerase active site and may have use as potential telomerase inhibitors.
Keywords: Coumarin, Dihydropyrazole, Molecular Docking, Antitumor Agent, Anticancer activity, Telomerase inhibitiors, Immortality, Ageing makes, Age-associated disorders, Human gastric cancer, Human liver cancer, Cytostatic properties, Cytotoxic activity, Mammalian cancer, Small bioactive molecule, CB1 antagonist, Docking simulation, Telomerase 3DU6, XT-4 binocular microscope, Pulse Fourier-transform NMR spectrometer, Analytical reagent-grade, Human gastric cell, Potent inhibitor, Telomerase, Binding mode, ATP binding site
Letters in Drug Design & Discovery
Title: Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity
Volume: 7 Issue: 9
Author(s): Zheng-Yu Cai, Yang Yang, Xin-Hua Liu and Xing-Bao Qi
Affiliation:
Keywords: Coumarin, Dihydropyrazole, Molecular Docking, Antitumor Agent, Anticancer activity, Telomerase inhibitiors, Immortality, Ageing makes, Age-associated disorders, Human gastric cancer, Human liver cancer, Cytostatic properties, Cytotoxic activity, Mammalian cancer, Small bioactive molecule, CB1 antagonist, Docking simulation, Telomerase 3DU6, XT-4 binocular microscope, Pulse Fourier-transform NMR spectrometer, Analytical reagent-grade, Human gastric cell, Potent inhibitor, Telomerase, Binding mode, ATP binding site
Abstract: A series of novel coumarin derivatives containing 4,5-dihydropyrazole moiety as potential telomerase inhibitors were synthesized. The bioassay tests showed that compound 3b exhibited potentially high activity against human gastric cancer cell SGC-7901 with IC50 value was 2.98±0.16. Docking simulation was performed to position compound 3b into the telomerase (3DU6) active site to determine the probable binding model. The result shows that some coumarin containing 4,5-dihydropyrazole moiety can combine well with the telomerase active site and may have use as potential telomerase inhibitors.
Export Options
About this article
Cite this article as:
Cai Zheng-Yu, Yang Yang, Liu Xin-Hua and Qi Xing-Bao, Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1H-pyrazol-3-yl)-7-fluoro-2H-chromen-2-one Derivatives: Synthesis and Anticancer Activity, Letters in Drug Design & Discovery 2010; 7 (9) . https://dx.doi.org/10.2174/157018010792929540
DOI https://dx.doi.org/10.2174/157018010792929540 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleuroparenchymal Fibroelastosis: Associations and Underlying Conditions
Current Respiratory Medicine Reviews The TCR/CD3 Complex: Opening the Gate to Successful Vaccination
Current Pharmaceutical Design Remodelling of the Ca2+ Toolkit in Tumor Endothelium as a Crucial Responsible for the Resistance to Anticancer Therapies
Current Signal Transduction Therapy Recent Advances in PUVA Photochemotherapy and PDT for the Treatment of Cancer
Current Pharmaceutical Design Evaluation of the Risk/Benefit Ratio of Old and New Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Fetal Mesenchymal Stem Cells in Cancer Therapy
Current Stem Cell Research & Therapy Molecular Mechanisms of Action of Gas1 and its Possible Therapeutic Applications
Current Signal Transduction Therapy Proteinases as Biomarkers in Breast Cancer Prognosis and Diagnosis
Mini-Reviews in Medicinal Chemistry Targeted Therapies in Solid Tumours: Pinpointing the Tumours Achilles Heel
Current Pharmaceutical Design Novel 4- Aryl-2(1H)-phthalazinone Derivatives as Cyclooxygenase-2 Inhibitors: Synthesis, Molecular Modeling Study and Evaluation as Promising Anti-inflammatory Agents
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Artepillin C: A Review
Letters in Drug Design & Discovery Cancer Stem Cell Markers in Nasopharyngeal Carcinoma and Its Relevance for Therapy
Current Traditional Medicine Editorial [ Hot Topic:Proton Dynamics in Cancer (Executive Guest Editor: Agustin Hernandez )]
Current Pharmaceutical Design Interaction of Wharton's Jelly Derived Fetal Mesenchymal Cells with Tumor Cells
Current Stem Cell Research & Therapy Spirulina paltensis: Food and Function
Current Nutrition & Food Science Novel and Emerging Targeted Therapies of Colorectal Cancer
Current Clinical Pharmacology Hemicellulose from Plant Biomass in Medical and Pharmaceutical Application: A Critical Review
Current Medicinal Chemistry Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Current Medicinal Chemistry Combined Evaluation of Expression of CXCR4 and Nrf2 as Prognostic Factor for Patients with Gastric Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Tissue Fatty Acid Profile is Differently Modulated from Olive Oil and Omega-3 Polyunsaturated Fatty Acids in ApcMin/+ Mice
Endocrine, Metabolic & Immune Disorders - Drug Targets